Table 2 Trial schedule, *imaging is done by CT or MRI or PET/CT, RT = radiotherapy
Inclusion in trial | Planning of RT (week -2) | RT (week 0–2) | End of RT (week 2) | Follow-up 1 (month 3) | Follow-up 2 (month 6) | Follow-up 3 (month 9) | Follow-up 4 (month 12) | Follow-up 5 (month 15) | |
|---|---|---|---|---|---|---|---|---|---|
Eligibility | x | ||||||||
Written informed consent | x | ||||||||
Medical History (incl. Histology) | x | x | x | x | x | x | x | ||
Karnofsky performance score | x | x | x | x | x | x | x | ||
Height | x | ||||||||
Weight | x | x | x | x | x | x | x | ||
Blood sample (CA 19–9, CEA) | x | x | x | x | x | x | |||
QLQ-C30 and QLQ-PAN26 | x | x | x | x | x | x | x | ||
Toxicity (NCI CTC AE V5.0) | x | x | x | x | x | x | x | ||
Staging imaging* (< 2 months old) | x | ||||||||
Imaging* of the upper abdomen | x | x | x | x | x | ||||
CT of the chest | x | x | |||||||
Planning CT | x | ||||||||
Image-guidance during RT | x |